EUDAMED Connector

Onboard, transform, and validate device data to automate M2M submissions to EUDAMED.

EUDAMED Connector
ATRIFY Connector

Transform, validate, and synchronize GDSN-compliant product data with your trading partners via atrify.

ATRIFY Connector
Success Story
Success Story

B. Braun implemented Innovit’s EUDAMED Connector to automate UDI submissions, enabling data onboarding from SAP, native EUDAMED-compliant data validation, and secure machine-to-machine data exchange with EUDAMED.

Featured Article
EUDAMED Compliance Guide for Device Manufacturers

Get practical, step-by-step guidance that translates regulatory and database requirements into actionable tasks that help you prepare, validate, and submit compliant device data to EUDAMED.

Featured Article
Celebrating 25 years of Bringing quality to master data!

Read a special note from Bang Chau reflecting on 25 years of bringing quality to master data, celebrating our journey, milestones, and continued commitment to data excellence in healthcare.

Timeline

AusUDID Timeline Explained: Key Dates, Implementation Milestones and Deadlines

This guide is for medical device and IVD manufacturers, Australian sponsors, and regulatory teams that need to understand when Australia’s UDI requirements apply to their devices, with particular emphasis on AusUDID submission timelines.

This guide focuses specifically on the AusUDID implementation timeline, including standard compliance dates by device class, existing-device provisions, MDD-to-MDR and IVDD-to-IVDR transitions, and direct-marking deadlines. It does not cover UDI data requirements, labelling rules, submission methods, or the technical steps required to achieve compliance.

Introduction 

Australia’s Unique Device Identification requirements are being introduced through a phased schedule that began with the highest-risk medical devices on 1 July 2026 and extends through 2030. The Australian UDI regulatory framework was established in March 2025, but the date that UDI requirements apply to an individual device depends on more than its classification. Manufacturers and sponsors may also need to consider existing-device provisions, European legacy-device transition arrangements, and separate direct-marking deadlines.

This guide explains the key AusUDID dates and how the different timelines fit together.

AusUDID Standard Compliance Timeline

Australia is introducing UDI requirements progressively based on device risk classification. Higher-risk medical devices entered mandatory compliance first, followed by lower-risk medical devices and IVDs.

The standard compliance schedule is:

1 July 2026: Class III and Class IIb

Australia’s first mandatory UDI requirements took effect on 1 July 2026 for Class III and Class IIb medical devices.

Devices within scope generally became subject to Australia’s UDI requirements from this date, including applicable UDI labelling and submission of device information to the AusUDID.

Certain existing or European legacy devices may qualify for different transition dates, as explained later in this document.

1 July 2027: Class IIa

Class IIa medical devices are the next group, with standard UDI requirements beginning on 1 July 2027.

Manufacturers may voluntarily comply before their mandatory date, provided the applicable Australian UDI requirements are met.

1 July 2028: Class Is and Class 3 & 4 IVDs

On 1 July 2028, the standard rollout expands to Class Is medical devices and Class 3 and Class 4 IVDs.

1 July 2029: Class 1 & 2 IVDs

The final standard class-based milestone is 1 July 2029, when Class 1 and Class 2 IVDs enter mandatory UDI compliance.

Some transition and direct-marking requirements continue beyond this date.

Key Takeaway

The standard rollout progresses from Class III and IIb in 2026 through to Class 1 and 2 IVDs in 2029. However, the standard date may not be the date that ultimately applies to every device.

Existing Device Transition Timeline

The standard compliance date does not necessarily mean every device manufactured before that date must immediately be relabelled.

For most device classes, devices manufactured and labelled before their applicable UDI compliance date can qualify for an exemption from UDI requirements for the lifetime of that device.

There is an important additional transition period for certain Class III and Class IIb devices.

Class III and Class IIb devices manufactured and labelled before 1 July 2026 and still under the sponsor’s control are subject to a transition period extending to 1 July 2029. By that date, applicable devices remaining under sponsor control must meet the relevant UDI requirements.

This makes 1 July 2029 an important secondary deadline for sponsors holding existing Class III or Class IIb inventory.

Key Takeaway

Do not assume that every device manufactured before its standard UDI date is permanently exempt. Certain existing Class III and IIb devices have a 1 July 2029 transition deadline.

MDD-to-MDR Transition Timeline

Australia provides additional transition time for certain devices that continue to rely on eligible certificates issued under the European Medical Devices Directive (MDD) while transitioning to the Medical Device Regulation (MDR).

For eligible devices, the Australian UDI transition dates include:

These dates do not automatically apply to every device previously certified under the MDD. The device must qualify for the applicable European transitional arrangements.

There is also an important earlier-compliance rule. If an eligible legacy device transitions to MDR compliance and becomes UDI compliant before its Australian transition deadline, Australia’s UDI requirements apply from that earlier point.

Key Takeaway

Eligible MDD legacy devices may receive additional time, but completing the MDR and UDI transition earlier can also bring the Australian UDI requirement forward.

IVDD-to-IVDR Transition Timeline

Similar transitional arrangements apply to eligible IVDs moving from the European IVDD to the IVDR.

Relevant Australian transition dates include:

Eligibility depends on the device meeting the applicable conditions for the European IVDD-to-IVDR transition.

As with MDD legacy devices, if an eligible IVD transitions to IVDR compliance and becomes UDI compliant before its Australian transition deadline, the Australian UDI requirements apply from that earlier point.

Key Takeaway

Eligible IVDD legacy devices can have later Australian UDI transition dates, extending to 1 January 2030 for certain Class 2 IVDs.

Direct Marking Compliance Timeline

Direct marking follows a separate schedule from standard UDI labelling and AusUDID data submission.

It generally applies to reusable devices that are reprocessed before subsequent use, subject to applicable exemptions. Implantable devices are among the devices exempt from Australia’s direct-marking requirement.

The direct-marking schedule is:

Devices manufactured and labelled before their applicable direct-marking date may qualify for an exemption from direct marking for the lifetime of the device.

The important distinction is that standard UDI compliance and direct marking are separate milestones. A reusable device can therefore become subject to UDI labelling and AusUDID requirements before the requirement to place the UDI directly on the device takes effect.

Key Takeaway

Direct marking is phased in later than standard UDI requirements, with the final scheduled requirements beginning on 1 July 2030.

AusUDID Timeline at a Glance

The major milestones can be summarized as follows:

Which AusUDID Date Applies to Your Device?

To determine the relevant deadline, manufacturers and sponsors should work through four questions:

  1. What is the device classification? Start with its standard UDI compliance date.
  2. Was the device manufactured and labelled before that date? Determine whether an existing-device provision applies.
  3. Is it an eligible European legacy device? Check whether an MDD-to-MDR or IVDD-to-IVDR transition date applies.
  4. Does direct marking apply? If so, identify the separate direct-marking deadline.

Conclusion

Australia’s UDI rollout is best understood as several overlapping timelines rather than a single compliance deadline.

The standard schedule began with Class III and Class IIb devices on 1 July 2026, followed by Class IIa in 2027, Class Is and Class 3 & 4 IVDs in 2028, and Class 1 & 2 IVDs in 2029.

The date that ultimately applies to a particular device can differ because of existing-device provisions, European legacy-device transitions, and direct-marking requirements.

Manufacturers and sponsors should therefore start with the standard date for the device classification and then determine whether any applicable transition or direct-marking provisions change the compliance timeline.

ACCESS NOW

View the Full Content

Fill out the form below to gain access to the full content.

Share This Content

Explore More

Continue exploring related content and deepen your understanding

AusUDID Compliance Guide for Device Manufacturers
Guide

AusUDID Compliance Guide for Device Manufacturers and Sponsors

AusUDID FAQ
FAQ

AusUDID Compliance FAQ for Device Manufacturers and Sponsors

AUSUDID Connector Datasheet
Datasheet

Innovit AUSUDID Connector

Ready to Simplify Your AusUDID Compliance?

Streamline TGA UDI submissions, improve data quality, and ensure faster regulatory compliance.